-
Mashup Score: 0
Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight…
Source: retinatoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5The long-term impact of anti-VEGF therapy for DME - 15 day(s) ago
Retina Specialist focuses on the latest advances in the diagnosis, medical management and surgical treatment of diseases of the retina, along with practical, real-world advice from leading clinicians and other experts on managing the successful retina practice.
Source: www.retina-specialist.comCategories: General Medicine News, OphthalmologyTweet-
Clinical trials have shown the promise of various anti-VEGF therapies in conserving visual acuity for DME patients — but what about DME patients in the real world? Two MDs present current evidence on the extended effectiveness of anti-VEGF for DME: https://t.co/WSWM5OYbTC #retina https://t.co/kZXfTpWw3A
-
-
Mashup Score: 5The long-term impact of anti-VEGF therapy for DME - 16 day(s) ago
Retina Specialist focuses on the latest advances in the diagnosis, medical management and surgical treatment of diseases of the retina, along with practical, real-world advice from leading clinicians and other experts on managing the successful retina practice.
Source: www.retina-specialist.comCategories: General Medicine News, OphthalmologyTweet-
Clinical trials have shown the promise of various anti-VEGF therapies in conserving visual acuity for DME patients — but what about DME patients in the real world? Two MDs present current evidence on the extended effectiveness of anti-VEGF for DME: https://t.co/WSWM5OYbTC #retina https://t.co/kZXfTpWw3A
-
-
Mashup Score: 0
Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight…
Source: retinatoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1
Two biosimilars are approved for use in retina by the US FDA—and more will be approved in the coming years. What exactly are biosimilars? What benefit might they provide? And how confident are retina specialist that biosimilars will deliver safe,…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Switch Case: Massive PED (Part 1) - Eyetube - 29 day(s) ago
What happens when a patient who presents with intermediate AMD returns with wet AMD and a massive pigment epithelial detachment (PED)? And after switching anti-VEGF agents to achieve longer durability, how do you account for vision loss despite resolution…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet-
Patient w/ intermediate AMD progresses to wet AMD with a massive PED. Despite switching anti-VEGF agents, vision loss occurs post-exudative activity resolution. Dr. Yasha Modi discusses this case with #retina specialists Drs. Joe Coney & Priya Vakharia: https://t.co/yYIiWAslXm https://t.co/Kz2A61tjNQ
-
-
Mashup Score: 2AAO ’23: Downward Trends in Reimbursement and ChatGPT in the Retina Clinic - Eyetube - 3 month(s) ago
Reimbursements for vitreoretinal surgery have plummeted in the past decade. How dire is the situation? John Thompson, MD, updates listeners on the trends in Medicare reimbursement for a variety of vitreoretinal surgeries, imaging tests, and E&M…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 6New Retina Radio AAO Late-Breakers: PULSAR at 96 Weeks and Home OCT in Wet AMD - Eyetube - 3 month(s) ago
They’re here: the 96-week data on aflibercept 8 mg (Eylea, Regeneron) in wet AMD. Jean-François Korobelnik, MD, PhD stops by to review the 96-week data from PULSAR. How closely did the 96-week results match those at 48 weeks? And how many patients…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1Intentional Suspension of Therapy in Wet AMD - Eyetube - 4 month(s) ago
What are the consequences to intentional suspension of anti-VEGF therapy in wet AMD patients? Join moderator Sruthi Arepalli, MD, and panelists Rebecca Soares, MD, MPH, and Vaidehi Dedania, MD, as they explore the circumstances under which treatment might…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5Case Files From the Clinic: Real-World Patient Profiles - Eyetube - 4 month(s) ago
How are leading retina specialists leveraging anti-VEGF agents to treat patients with wet AMD and DME? Join Priya Sharma Vakharia, MD; Joseph M. Coney, MD; and Jordan M. Graff, MD, as they review a variety of real-world cases from their clinics and use…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
Want an update on the latest #retina pipeline candidates for GA and nAMD? Join Peter Kaiser, MD, on a journey through Retina Today's interactive digital infographic: https://t.co/UOelNDZkHD https://t.co/hbobr6Kcwe